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Abstract: Taurine bromamine (Tau-NHBr) is produced by the reaction between hypobromous acid
(HOBr) and the amino acid taurine. There are increasing number of applications of Tau-NHBr as an
anti-inflammatory and microbicidal drug for topical usage. Here, we performed a comprehensive
study of the chemical reactivity of Tau-NHBr with endogenous and non-endogenous compounds.
Tau-NHBr reactivity was compared with HOBr, hypochlorous acid (HOCl) and taurine chloramine
(Tau-NHCl). The second-order rate constants (k2) for the reactions between Tau-NHBr and tryptophan
(7.7 ˆ 102 M´1s´1), melatonin (7.3 ˆ 103 M´1s´1), serotonin (2.9 ˆ 103 M´1s´1), dansylglycine
(9.5 ˆ 101 M´1s´1), tetramethylbenzidine (6.4 ˆ 102 M´1s´1) and H2O2 (3.9 ˆ M´1s´1) were
obtained. Tau-NHBr demonstrated the following selectivity regarding its reactivity with free amino
acids: tryptophan > cysteine ~ methionine > tyrosine. The reactivity of Tau-NHBr was strongly
affected by the pH of the medium (for instance with dansylglycine: pH 5.0, 1.1 ˆ 104 M´1s´1, pH 7.0,
9.5 ˆ 10 M´1s´1 and pH 9.0, 1.7 ˆ 10 M´1s´1), a property that is related to the formation of the
dibromamine form at acidic pH (Tau-NBr2). The formation of singlet oxygen was observed in the
reaction between Tau-NHBr and H2O2. Tau-NHBr was also able to react with linoleic acid, but with
low efficiency compared with HOBr and HOCl. Compared with HOBr, Tau-NHBr was not able to
react with nucleosides. In conclusion, the following reactivity sequence was established: HOBr >
HOCl > Tau-NHBr > Tau-NHCl. These findings can be very helpful for researchers interested in
biological applications of taurine haloamines.
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1. Introduction
Hypochlorous acid (HOCl) and hypobromous acid (HOBr) are microbicidal agents produced
when the white blood cells, neutrophils and eosinophils, respectively, are challenged by stimuli like
bacteria and fungi [1]. Eosinophils, in particular, are associated with the host defense against parasitic
helminth infections and asthma exacerbation [2,3]. These halogenating and oxidizing agents also play
an important role in tissue damage associated with chronic inflammatory diseases [4,5]. For instance,
eosinophilia, a characteristic of asthmatic subjects [6] has been associated with an increased level of
3-bromotyrosine, a biomarker of the damaging effects of HOBr [7].
The formation of these oxidants is due to the large amount of the enzymes myeloperoxidase (MPO)
and eosinophil peroxidase (EPO) in these cells, which promote the catalytic oxidation of chloride
(Cl´) and bromide (Br´) to HOCl and HOBr, respectively [8,9]. The catalytic mechanism involves the
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transient production of the redox active compounds, named compound I (MPO-I and EPO-I), which
are two electron oxidized compared with the native enzyme. An important difference between MPO-I
and EPO-I is their standard reduction potential [10]. Thus, while MPO-I (1.16 V) is able to oxidize
efficiently both Cl´ and Br´ [11]; EPO-I (1.09 V) shows a large preference for Br´ [12]. This chemical
feature, the higher plasma level of Cl´ (~100 mM) compared with Br´ (~100 µM), and the higher
oxidant capacity of HOCl (1.28 V) compared with HOBr (1.13 V) [13], could suggest that the biological
effect of HOBr would be irrelevant compared with HOCl. However, this does not seem to be the case,
since there is significant evidence that HOBr is more reactive with several biomolecules compared to
HOCl [14,15]. This phenomenon is the consequence of the higher electrophilicity of HOBr compared
to HOCl [16].
Taurine bromamine (Tau-NHBr) is a chemical produced by the reaction between HOBr and the
non-essential amino acid taurine. Yazdanbakhsh et al. provided the first application of Tau-NHBr
and proposed its endogenous formation [17]. These authors found that stimulated eosinophils could
be a source of Tau-NHBr, since these cells may produce HOBr, and taurine is abundantly present in
leukocytes. It is interesting to note that this finding took place just one year after the discovery that
eosinophils could produce and release HOBr [18].
Currently, Tau-NHBr is used as an anti-inflammatory and a topical antimicrobial drug.
Some examples of its applications are its use as a therapeutic agent for the treatment of acne
vulgares [19,20]; treatment of biofilm-associated infections on dental surfaces caused by Pseudomonas
aeruginosa [21,22]; microbicidal activity against Escherichia coli and Staphylococcus aureus at insensitive
body regions with low organic matter [23]; inhibition of the production of inflammatory mediators,
such as prostaglandin E2 (PGE2), nitric oxide (NO) and pro-inflammatory cytokines [24]; and
inhibition of degradation of TNF-α-induced Nuclear Factor-kappaB activation in Jurkat cells and
myeloid-committed eosinophils [25]. The equivalent chlorinated haloamine is taurine chloramine
(Tau-NHCl), which is the reaction product of the interaction between taurine and HOCl. Tau-NHCl
is produced by activated neutrophils and released at inflammatory sites, inhibiting the production
of inflammatory mediators [26]. An important chemical feature of Tau-NHCl, which makes this
compound so interesting and extensively studied, is its mild oxidant capacity compared to its precursor
HOCl. Thus, Tau-NHCl is able to oxidize selectively sulfhydryl residues in proteins [27], and to act
as an endogenous antioxidant [28]. These aspects might be involved in the signaling pathways
susceptible to Tau-NHCl [29,30]. There are also a large number of applications for Tau-NHCl as a
topical anti-inflammatory and anti-infective drug [31].
In contrast to Tau-NHCl, for which the chemical properties have been intensively studied [32],
much less is known about Tau-NHBr. This was our motivation for undertaking this study. Here, the
reactivity of Tau-NHBr was evaluated and compared with HOBr, HOCl and Tau-NHCl, using several
endogenous and non-endogenous chemicals. Using fast kinetic techniques, it was possible to measure
the bimolecular rate constants of these reactions. We believe that this chemical data will be helpful for
those interested in the application of this interesting compound.
2. Results and Discussion
2.1. Preparation and Stability of Tau-NHBr
Tau-NHBr can be prepared by reacting HOBr with taurine (Equation 1). However, it exists in
equilibrium with its dibromamine form (Tau-NBr2) and, as has been demonstrated by Thomas et al.,
pure Tau-NHBr is only obtained using a large excess of taurine. In our studies, we usually prepare
stock solutions of Tau-NHBr by reacting 5 mM HOBr with 500 mM taurine in 50 mM phosphate buffer,
pH 7.0, i.e., a 100-fold excess of taurine. This solution was very stable when stored in the refrigerator
and lost less than 20% of its initial concentration after five weeks [33].
HO3SCH2CH2NH2 ` HOBr Ñ HO3SCH2CH2NHBr
pTaurineq pTau´NHBrq, (1)
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2.2. Reactivity with Tryptophan
Aiming to obtain a comprehensive knowledge of the chemical reactivity of Tau-NHBr, we used
endogenous and non-endogenous compounds as potential targets. The first target was tryptophan,
whose reactivity with HOCl and HOBr has been described [34,35]. Figure 1a shows the time-dependent
fluorescence decay of tryptophan by the addition of Tau-NHBr. In these experiments, the concentration
of tryptophan was kept constant at 25 µM and the concentration of Tau-NHBr was varied from
100 to 500 µM. From this pseudo-first-order experimental condition, the apparent second-order rate
constant (k2) was calculated (7.7 ˆ 102 M´1s´1, Figure 1b). To gain insight into the significance of this
value, it was compared with those obtained using HOBr, HOCl and Tau-NHCl. Figure 1a shows that,
whereas 150 µM Tau-NHBr provoked the tryptophan fluorescence decay in about 20 s, HOBr caused
the same effect in less than 0.02 s (Figure 1c). Unfortunately, this reaction was too fast to determine
k2; however, its higher reactivity compared to Tau-NHBr was evident. Regarding HOCl, we took as
reference a recent determination performed in our laboratory using exactly the same analytical protocol
(k2 = 8.1ˆ104 M´1s´1) [15]. Finally, and in agreement with the well-known low reactivity of
Tau-NHCl [31], we found that this haloamine was unreactive with tryptophan. In fact, the experiments
were done using up to a 10-fold excess of Tau-NHCl compared with Tau-NHBr, but no indication of
consumption of tryptophan was observed for up to 10 min. From these results, the following reactivity
sequence was obtained: HOBr > HOCl > Tau-NHBr > Tau-NHCl (unreactive).
Besides tryptophan, the reactivity of Tau-NHBr with melatonin and serotonin was also obtained.
These tryptophan derivatives have many physiological functions, including endogenous antioxidative
activity [36,37]. Among others factors, this property is related to the lower one-electron reduction
potential of these molecules compared to tryptophan (tryptophan E˝’ = 1.01 V, melatonin E˝’ = 0.95 V,
and serotonin E˝’ = 0.65 V) [38]. In agreement, the k2 values obtained for melatonin (7.3 ˆ 103 M´1s´1)
and serotonin (2.9 ˆ 103 M´1s´1) were about 10-fold higher compared to tryptophan (Figure 2).
2.3. Reactivity with Dansylglycine
In contrast to tryptophan, which has significant intrinsic fluorescence, other oxidizable amino
acids, like methionine and cysteine, are not fluorescent. Tyrosine is also fluorescent, but with its
maximum excitation/emission at 280/305 nm, our application of a stopped-flow system coupled
to a LED source (280 nm) and the emission cut-off filters (305 nm) made the determination of k2
unworkable. Thus, instead of a direct measurement of the reaction rate, an indirect procedure was
performed by comparing the effect of these amino acids with the reaction rate of dansylglycine and
Tau-NHBr. Dansylglycine is a fluorescent probe used for attribution of binding sites in albumin [39].
This probe was selected for several reasons, including our previous determination of its bimolecular
rate constant with HOBr and HOCl [15], its fluorescence properties (λex 360 nm, λem 550 nm), which
made the spectral interference of the studied compounds minimal, and its application as a probe for
tryptophan residues in albumin, as will be demonstrated below.
Before the use of dansylglycine for the comparison of the reactivity of these amino acids, the
measurement of its apparent second-order rate constant with Tau-NHBr was performed (Figure 3).
Corroborant with the tryptophan results, the obtained k2 (9.5 ˆ 101 M´1s´1) was significantly lower
than for HOBr (7.3ˆ 106 M´1s´1) and HOCl (5.2ˆ 102 M´1s´1) [15]. Tau-NHCl was totally unreactive
with dansylglycine. The following reactivity sequence again was established: HOBr > HOCl >
Tau-NHBr > Tau-NHCl.
2.4. Relative Reactivity with Tryptophan, Tyrosine, Cysteine and Methionine
Following the analytical protocol established above, the selectivity of Tau-NHBr with the
oxidizable amino acids was evaluated by measuring and comparing tryptophan, tyrosine, cysteine
and methionine in regard to their efficacy as inhibitors of the oxidation of dansylglycine.
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The results displayed in Figure 4 show the effect of tryptophan and tyrosine in the fluorescence
bleaching of dansylglycine. It can be observed that, whereas tryptophan was an effective competitor
and significantly inhibited the depletion of dansylglycine, tyrosine was much less effective. From
these experiments, the relative reactivity of the amino acids was calculated as the slope of the curve
(kobs versus amino acid concentration). The results were tryptophan 2.4 ˆ 10´4 ∆kobs/mM (Figure 4b)
and tyrosine 1.3 ˆ 10´5 ∆kobs/mM (Figure 4d), showing that tryptophan was about an 18-fold better
inhibitor, or, in other words, 18-fold more reactive with Tau-NHBr compared with tyrosine.
Following the same experimental concept, the effects of cysteine and methionine on dansylglycine
bleaching were also measured. The slope of the curve of the pseudo first-order rate constant versus
amino acid concentration was cysteine 8.7 ˆ 10´5 ∆kobs/mM and methionine 6.5 ˆ 10´5 ∆kobs/mM
(Figure 5). Hence, the following sequence of relative reactivity of Tau-NHBr was established:
tryptophan > cysteine ~ methionine > tyrosine.
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consumption for determination of kobs under pseudo-first-order experimental conditions. The reaction 
mixture was composed of 25 µM tryptophan and increasing concentrations of Tau-NHBr in 50 mM 
phosphate buffer, pH 7.0 at 25 °C. The stopped-flow system was set as follows: excitation, 280 nm 
LED; and emission, 325 nm cut-off filter; (b) Determination of the bimolecular rate constant (k2) for 
the reaction between tryptophan and Tau-NHBr; (c) Kinetic profile of tryptophan (25 µM) 
consumption by HOBr (50 µM). The results are the mean of three experiments. 
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Figure 1. Reactivity of Tau-NHBr and HOBr with tryptophan. (a) Kinetic profile of tryptophan
consumption for determination of kobs under pseudo-first-order experimental conditions. The reaction
mixture was composed of 25 µM tryptophan and increasing concentrations of Tau-NHBr in 50 mM
phosphate buffer, pH 7.0 at 25 ˝C. The stopped-flow system was set as follows: excitation, 280 nm
LED; and emission, 325 nm cut-off filter; (b) Determination of the bimolecular rate constant (k2) for the
reacti betwee tryptophan and Tau-NHBr; (c) Kinetic profile of tryptophan (25 µM) consumption by
HOBr (50 µM). The results are the mean of three experiments.
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Figure 2. Reactivity of Tau-NHBr with melatonin and serotonin. Kinetic profile of (a) Melatonin and
(c) Serotonin consumption for determination of kobs under pseudo-first-order experimental conditions.
The reaction mixture was composed of 25 µM indoles and increasing concentrations of Tau-NHBr in
50 mM phosphate buffer, pH 7.0 at 25 ˝C. The stopped-flow system was set as follows: excitation,
280 nm LED; and emission, 325 nm cut-off filter. Determination of the bimolecular rate constant (k2)
for the reaction between (b) Melatonin and (d) Serotonin with Tau-NHBr. The results are the mean of
three experiments.
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Figure 3. Re ctivity f Tau-NHBr with dans lglycine. ( ) Ki etic profile of dansylglycine consumption
for determination of kobs under pseudo-first-order experimental conditions. The reaction mixture
was composed of 25 µM dansylglycine (DG) and increasing concentrations of Tau-NHBr in 50 mM
phosphate buffer, pH 7.0 at 25 ˝C. The stopped-flow system was set as follows: excitation, 360 nm LED;
and emission, 475 nm cut-off filter; (b) Determination of k2 for the reaction between dansylglycine and
Tau-NHBr. The results are the mean of three experiments.
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Figure 4. Tryptophan versus tyrosine as targets for Tau-NHBr. (a) Reaction of dansylglycine with
Tau-NHBr and the effect of tryptophan; (b) Effect of tryptophan on the pseudo-first-order reaction
rate of dansylglycine with Tau-NHBr; (c) Reaction of dansylglycine with Tau-NHBr and the effect of
tyrosine; (d) Effect of tyrosine on the pseudo-first-order reaction rate of dansylglycine with Tau-NHBr.
The reaction mixture was composed of 25 µM dansylglycine, 500 µM Tau-NHBr and increasing
concentrations of amino acids in 50 mM phosphate buffer, pH 7.0. The stopped-flow system was set as
follows: excitation, 360 nm LED; and emission, 475 nm cut-off filter.
2.5. Selectivity upon Tryptophan Residues in Proteins
As we have demonstrated above, Tau-NHBr has lower oxida t capacity compared to its precursor
HOBr nd HOCl. In this context, it is worth oting a principle of chemistry: lower reactivity usually
implies greater selectivity. This principle seems to be applicable in our studies, because, in contrast
to HOBr nd HOCl, Tau-NHBr was able to oxidize tryptophan b t not tyrosine. Following this
idea, we sus ect that our recent proposal for the selectivity of Tau-NHBr [40] and Tau-NBr2 [41] for
tryptophan residues in albumin and lysozyme could be reinforced by these new findings. Thus, aiming
to advance this proposal, dansylglycine was used to probe the depletion of tryptophan in human
serum albumin (HSA).
Dansylglycine is a ligand of albumin. Its complexation can be monitored by an increased
fluorescence quantum yield and a blue shift in the emission band, and, more importantly for our
purpose, dansylated amino acids can be excited by fluorescence resonance energy transfer from
tryptophan in HSA [42]. To make sure that this property is also applicable to dansylglycine, we added
increasing concentrations of this compound to a fixed concentration of HSA. Our expectation was
confirmed because dansylglycine was not fluorescent when excited at 295 nm; however, in the presence
of HSA, the addition of increasing amounts of dansylglycine provoked a gradual quenching of the
intrinsic fluorescence of the protein and a concomitant increase in the fluorescence of dansylglycine.
Considering these findings, dansylglycine was used as a probe for evaluation of the consumption
of tryptophan in HSA provoked oxidation. In these experiments, the oxidation was provoked by
adding a 20-fold excess of the oxidants and, after five minutes, methionine was added to deplete the
excess of oxidants. The results depicted in Figure 6a confirmed our expectation of selectivity because,
though much less reactive with free tryptophan, Tau-NHBr was more effective than HOCl or HOBr in
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depleting the intrinsic fluorescence of HSA, which is mainly due to tryptophan residues when excited
at 295 nm [43]. In others words, Tau-NHBr seems to act mainly on tryptophan residues of the protein.
Figure 6b shows the effect of the addition of dansylglycine after oxidation and depletion of the oxidant
excess. The band at 485 nm was lower in the sample oxidized with Tau-NHBr, which is an additional
confirmation that tryptophan residues were more efficiently oxidized using this oxidant, since the
measured fluorescence was due to energy transfer from the tryptophan residues in HSA.
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Figure 5. Cysteine versus methionine as targets for Tau-NHBr. (a) Reaction of dansylglycine with
Tau-NHBr and the effect of cysteine; (b) Effect of cysteine on the pseudo-first-order reaction rate
of dansylglycine with Tau-NHBr; (c) Reaction of dansylglycine with Tau-NHBr and the effect of
methionine; (d) Effect of methionine on the pseudo-first-order reaction rate of dansylglycine with
Tau-NHBr. The reaction mixture was composed of 25 µM dansylglycine, 500 µM Tau-NHBr and
increasing concentrations of amino acids in 50 mM phosphate buffer, pH 7.0. The stopped-flow system
was set as follows: excitation, 360 nm LED; and emission, 475 nm cut-off filter.
2.6. Comparison between Tau-NHCl and Tau-NHBr
As we have demonstrated above, Tau-NHCl was unreactive with all studied compounds in this
work; which is, indeed, in agreement with its well-established poor oxidant capacity [32]. Obviously,
it does not mean that Tau-NHCl is completely devoid of oxidant capacity, as is confirmed, for
instance, by its capacity to oxidize sulfhydryl residues in proteins [27]. Tau-NHCl is also able to
oxidize 3,3’,5,5’-tetramethylbenzidine (TMB) in acid medium, the chromogenic substrate used for
determin ti n of the chlorination activity f MPO [44]. Thus, aiming to quantify the difference in
reactivity between Tau-NHBr and Tau-NHCl, w used TMB as the a get. I mu t also be noted
that instead of an acidic pH, the reaction was conducted at H 7.0, as was used for the other
compound studies in this work. It is important to emphasize this point, because its reactivity is
significantly lower at neutral pH, which is, indeed, the reason for the application of acidic medium for
determination of Tau-NHCl activity using TMB [44]. The results depicted in Figure 7 confirmed our
expectation, because, at pH 7.0, Tau-NHCl was able to oxidize TMB. Its oxidant efficacy was measured
(k2 = 3.1 M´1s´1) and, corroborant with the previous results, was about 100-fold lower than Tau-NHBr
(k2 = 6.4 ˆ 102 M´1s´1). The comparison was also made using the antioxidant curcumin, an oxidizable
Biomolecules 2016, 6, 23 8 of 17
polyphenol, as the target. The rate constants were 7.3 M´1s´1 and 38.2 M´1s´1 for Tau-NHCl and
Tau-NHBr, respectively (Figure 7).
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Figure 6. Oxidation of HSA by HOBr, HOCl and Tau-NHBr. (a) Reaction mixtures were composed
of 10 µM HSA and 200 µM oxidants in 5.0 mM phosphate buffer, pH 7.0. After five minutes, 250 mM
methionine was added and the HSA intrinsic fluorescence was measured at an excitation of 295 nm;
(b) Addition of 5 µM dansylglycine to the oxidized protein and its fluorescence obtained by energy
transfer from tryptophan residues.
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Figure 7. Tau-NHBr versus TauNHCl as oxidants of tetramethylbenzidine and curcumin.
(a,b) Determination of bimolecular rate constant (k2) for the reaction between TMB and Tau-NHBr
or Tau-NHCl. The reaction mixture was composed of 1.4 mM TMB and increasing concentrations of
haloamines in 50 mM phosphate buffer, pH 7.0; (c,d) Determination of the bimolecular rate constants
(k2) for the reactions between curcumin and Tau-NHBr or Tau-NHCl. The reaction mixture was
composed of 10 µM curcumin and increasing concentrations of haloamines in 50 mM phosphate buffer,
pH 7.0.
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2.7. pH Effect on Tau-NHBr Reactivity
In aqueous solutions, chloramine and bromamine are in equilibrium with their dichloramine and
dibromamine forms [32,33]. These dihalogenated structures are the results of the disproportionation
reaction, by which two molecules of Tau-NHX are converted to Tau-NX2 and taurine, respectively.
The conversion of Tau-NHCl to Tau-NHCl2 is pH dependent, being favored at acidic pH [32]. Here,
we found the same tendency for Tau-NHBr, which was progressively, converted to Tau-NBr2 as the
pH decreased. The results depicted in Figure 8a show the absorbance increase at 241 and 346 nm
and decrease at 288 nm, which provides evidence for the formation of Tau-NBr2 [33]. The chemical
equation below shows the equilibrium between the mono- and dihalogenated forms as well as the pH
dependence (Equation 2).
2 HO3SCH2CH2NHBr ` H` Ø HO3SCH2CH2NBr2 `HO3SCH2CH2NH3`
pTau´NHBrq pTau´NBr2q pTaurineq, (2)
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Figure 8. pH effect on Tau-NHBr reactivity. (a) Tau-NHBr (5 mM) was prepared in water using a
100-fold excess of taurine. The solution was diluted to 0.25 mM of NaH2PO4/Na2HPO4 (50 mM)
solutions combined to reach the indicated pH; (b,c) Reactivity of Tau-NHBr with dansylglycine at pH
5.0 and 9.0.
Next, we studied the effect of pH on the reactivity of Tau-NHBr. Figure 8 shows the k2 obtained for
the reactions between dansylglycine and Tau-NHBr at pH 5.0 and 9.0. The rate constants were (pH 5.0)
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1.1 ˆ 104 M´1s´1, (pH 7.0) 9.5 ˆ 101 M´1s´1 and (pH 9.0) 1.7 ˆ 101 M´1s´1. The pH dependence
can be explained by taking into account the higher reactivity of the dihalogenated forms, as has been
demonstrated for Tau-NCl2 [45].
2.8. Reactivity of Tau-NHBr with Hydrogen Peroxide and Formation of Singlet Oxygen
Another property that distinguishes Tau-NHCl from Tau-NHBr is the capacity of the latter to
react with H2O2 [33]. Here, this chemical property was confirmed and the k2 (3.9 M´1s´1) obtained by
measuring the decay of Tau-NHBr as a function of increasing concentrations of H2O2 (Figure 9).
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Figure 9. Reactivity of Tau-NHBr with H2O2. (a) Kinetic profile of Tau-NHBr consumption for
determination of kobs under pseudo-first-order experimental conditions. The reaction mixture was
composed of 250 µM Tau-NHBr and increasing concentrations of H2O2 in 50 mM phosphate buffer,
pH 7.0; (b) Determination of the bimolecular rate constant (k2) for the reaction between H2O2 and
Tau-NHBr.
Activated eosinophils are an important in vivo source of singlet oxygen. The formation of this
electronically excited form of oxygen is due to the reaction betwe n HOBr and H2O2 [46]. We found that
Tau-NHBr retains this capacity, as can be seen by the ultra-weak light emission produced during the
reaction cou se originating from the de ay f singlet oxygen (Figure 10a). It is important o emphasiz
that the extremely low light emission is due to the inadequacy of a c ventional luminom ter to
measure the emission of singlet oxygen, which emits in the infrared region (1200 nm). Hence, to gain
additional evidence of its production, we added melatonin to the reaction system. The results depicted
in Figure 10b show that the light emission increased almost two orders of magnitude compared to
the reaction without melatonin. The light emission is dependent on both H2O2 and melatonin, which
excluded the possibility of direct interaction between melatonin and Tau-NHBr or melatonin and
H2O2 as a source of the light emission. Thus, the increase in emission is consistent with the cleavage of
the pyrrole ring of melatonin and formation of N-acetyl-N-formyl-5-methoxykynuramine (AFMK), a
Biomolecules 2016, 6, 23 11 of 17
chemiluminescent reaction [47] that has been demonstrated between melatonin and singlet oxygen [48].
In accordance with this proposal, the formation of AFMK was also obtained here (Figure 10c).
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Figure 10. Evidence of oxygen singlet production. (a) Intrinsic light emission by the reaction of 0.25 mM
Tau-NHBr with 5 mM H2O2 in 50 mM phosphate buffer, pH 7.0; (b) Melatonin-mediated light emission
by the reaction consisting of 0.25 mM Tau-NHBr with 5 mM H2O2 and 1 mM melatonin in 50 mM
phosphate buffer, pH 7.0 (complete system); (c) HPLC analysis of the reaction mixture and evidence of
the formation of AFMK (peak at 6 min) obtained by comparison with a pure AFMK.
2.9. Reactivity of Tau-NHBr with Linoleic Acid
Among the biomolecules susceptible to the deleterious effects provoked by reactive oxygen species
(ROS), unsaturated fatty acids occupy an important position. As electrophilic reagents, HOCl and
HOBr are well established as inducers of the formation of halohydrin by reacting with the double bonds
in mono- and polyunsaturated fatty acids [49,50]. For this reason, we also investigated the reactivity of
Tau-NHBr with linoleic acid as a model of polyunsaturated fatty acids. In these experiments, linoleic
acid was incubated with the oxidants and their remaining concentration was measured using the
sulfhydryl reagent 5’-thio-2-nitrobenzoic acid (TNB). The results depicted in Figure 11 show that, while
HOCl and HOBr reacted promptly with linoleic acid and were totally consumed just after one minute
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of incubation, Tau-NHBr reacted slowly, with only 50% consumed in 60 min of incubation. As could
be expected from the previous results, Tau-NHCl was still less reactive.Biomolecules 2016, 6, 23 12 of 17 
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Figure 12. Reactivity of Tau-NHBr and HOBr with nucleosides. The reaction mixtures were composed
of 100 µM Tau-NHBr or HOBr and 100 µM nucleosides in 50 mM phosphate buffer, pH 7.0. After
30 min the remaining oxidants were measured by the TNB method. The results are the mean of
three experiments.
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3. Experimental Section
3.1. Chemicals and Solutions
Taurine, tryptophan, tyrosine, methionine, cysteine, melatonin, serotonin, N-acetyl-N-formyl-5-
methoxykynuramine (AFMK), TMB, 5,5’-dithiobis-(2-nitrobenzoic acid) (DTNB), dansylglycine,
linoleic acid, salicylic acid, curcumin, adenosine, cytidine, guanosine, thymidine, uridine and HSA
were purchased from Sigma-Aldrich Chemical Co. (St. Louis, MO, USA). The chemicals used for
preparation of phosphate buffers and others solutions were of analytical grade. HOCl was prepared
by diluting a 5% stock solution and the concentration was determined spectrophotometrically after
dilution in 0.01 M NaOH, pH 12 (ε292nm = 350 M´1cm´1). HOBr was synthesized by combining
100 mM HOCl and 200 mM NaBr in water [33]. Tau-NHCl was prepared by the addition of 5 mM
HOCl to 50 mM taurine in 50 mM sodium phosphate buffer at pH 7.0 and its concentration was
determined spectrophotometrically (ε252nm = 429 M´1cm´1) [25]. Tau-NHBr was prepared by the
addition of 5 mM HOBr to 500 mM taurine in 50 mM sodium phosphate buffer at pH 7.0 and its
concentration was determined spectrophotometrically (ε288nm = 430 M´1cm´1) [25]. TNB solution
was prepared by dissolving 2 mM DTNB in 50 mM phosphate buffer, pH 7.0. Then, this solution
was titrated to pH 12 with 0.1 M NaOH to promote its hydrolysis, and after 5 min the pH was
brought back to 7.4 with hydrochloric acid. Then, its concentration was determined by its absorbance
(ε412nm = 14,100 M´1cm´1) [54]. A Perkin Elmer Lambda 35 UV-visible spectrophotometer
(Manufacturer, Shelton, CT, USA) was used for the UV-Vis measurements.
3.2. Determination of Rate Constants
The reactivity of Tau-NHBr, HOBr and HOCl with the target molecules was obtained
by comparing their bimolecular rate constants, which were obtained using pseudo-first-order
experimental conditions. The fast-kinetic experiments were performed using a single-mixing
stopped-flow system equipped with a high intensity LED source and cut-off filters (SX20/LED
Stopped-Flow System, Applied Photophysics, City, UK). The observed pseudo-first-order rate constant
(kobs) was obtained by fitting the fluorescence or absorbance decay of the studied compound to a single
exponential decay equation, as follows (Equation 3):
S “ S0 ˆ e´kobs ˆ t, (3)
where:
S is the fluorescence or absorbance as a function of time
S0 is the initial fluorescence or absorbance
From the kobs values obtained at various concentrations, the bimolecular rate constants (k2) were
calculated from the slope of the linear regression as follows (Equation 4):
reaction rate “ k2ˆrAsˆ rBs, (4)
where [A] is the concentration of the haloamines or hypohalous acids and [B] is the concentration of the
studied compounds. From the pseudo-first-order experimental condition, the apparent second-order
rate constant (k2) was calculated (Equation 5).
If rAs" rBs, then, reaction rate “ kobsˆrBs
Then, kobs “ k2ˆrAs, (5)
The k2 is the slope of the linear fit of kobs versus [A]
The photophysical properties of the studied compounds and their intrinsic reactivity determined
the experimental conditions used to monitor each reaction. The specific absorbance or excitation
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and emission wavelengths used for monitoring each reaction are shown in the figure legends.
Unless otherwise stated, the concentrations of the target compounds were fixed at 25 µM, and the
concentrations of the oxidants were in the range of 100 to 500 µM. The reactions were performed in
50 mM phosphate buffer, pH 7.0 at 25 ˝C.
3.3. Oxidation of Human Albumin and the Use of Dansylglycine as a Fluorescent Probe for
Tryptophan Residues
The reaction mixtures were composed of 10 µM HSA and 200 µM oxidants in 50 mM phosphate
buffer, pH 7.0. After five minutes, 250 µM methionine was added and the fluorescence was measured
at an excitation wavelength of 295 nm and emission in the range of 310–450 nm was recorded. When
present, dansylglycine was added at 5 µM and emission was measured in the range of 450–600 nm.
The experiments were performed using a LS55 spectrofluorometer (Perkin-Elmer, Waltham, MA, USA).
For the experiments where HSA was oxidized in the presence of dansylglycine, the stopped-flow
system was set as follows: excitation, 280 nm LED, and emission, 455 nm cut-off filter.
3.4. Reactions with 3,3’,5,5’-tetramethylbenzidine (TMB), Curcumin, Hydrogen Peroxide and Linoleic Acid
3,3’,5,5’-tetramethylbenzidine: The reaction medium was composed of 1.4 mM TMB and
increasing concentrations of haloamines in 50 mM phosphate buffer, pH 7.0. The reaction was
monitored at 650 nm using conventional spectrophotometry.
Curcumin: The reaction medium was composed of 10 µM curcumin and increasing concentrations
of haloamines in 50 mM phosphate buffer, pH 7.0. The reaction was monitored at 425 nm using
conventional spectrophotometry.
Hydrogen peroxide: The reaction medium was composed of 250 µM Tau-NHBr and increasing
concentrations of H2O2 in 50 mM phosphate buffer, pH 7.0. The reaction was monitored at 288 nm using
conventional spectrophotometry. The reaction also was studied by chemiluminescence. In this case, the
measurement of light emission was performed using a Centro LB 960 microplate luminometer (Berthold
Technologies, Oak Ridge, TN, USA). The isolation and identification of oxidation products of melatonin
was performed by high performance liquid chromatography in line with a fluorescence detector set
at 340/460 nm (Jasco, Easton, MD, USA). The analyses were carried out isocratically on a Luna C18
reverse-phase column (250 ˆ 4.6 mm, 5 µm) using 70:30 aqueous formic acid 0.1%/acetonitrile (flow
rate 1.0 mL/min) as the mobile phase. The identification of AFMK as a product of the reaction was
performed by comparison with a pure standard of this compound.
Linoleic acid: The oxidants (50 µM) were incubated with 100 µM linoleic acid in 50 mM phosphate
buffer, pH 7.0 for increasing time intervals. Then, the remaining concentration of oxidants was measured
by the addition of 50 µM TNB, and the absorbance was measured at 412 nm (ε412nm = 14,100 M´1cm´1).
4. Conclusions
Tau-NHBr, an endogenous oxidant, has also been used as an anti-inflammatory compound and
topical antimicrobial agent. Here, we have identified several chemical properties of this promising drug.
The most important was its selectivity regarding tryptophan residues in proteins. By measuring the
bimolecular rate constant with several biomolecules, the following reactivity sequence was established:
HOBr > HOCl > Tau-NHBr > Tau-NHCl. The reactivity of Tau-NHBr was strongly affected by the pH
of the medium, a property related to the formation of the dibromamine form at acidic pH (Tau-NBr2).
The formation of singlet oxygen was observed in the reaction between Tau-NHBr and H2O2. In
conclusion, these findings could be very helpful for researchers interested in biological applications of
this taurine haloamine.
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